Concepedia

Judith Atz

JA

10

Publications

369

Citations

10

H-Index

1999

Active since

Affiliations

Neovii Biotech (Germany)(Current)

Johannes Gutenberg University Mainz

Brüderkrankenhaus St. Josef Paderborn

Boehringer Ingelheim (Germany)

Forschungsinstitut für Mineralische und Metallische Werkstoffe Edelsteine/Edemetalle

Judith Atz is an author at Neovii Biotech (Germany) specializing in radiation oncology, oncology, and tumor immunology.

Top concepts

Publications per year

1999–2022

10

Publications

10

Characterization of DP103, a Novel DEAD Box Protein That Binds to the Epstein-Barr Virus Nuclear Proteins EBNA2 and EBNA3C

Adam Grundhoff, Elisabeth Kremmer, Özlem Türeci et al. · Journal of Biological Chemistry · 1999 · 102 citations · Full text

Characterisation of the new EpCAM-specific antibody HO-3: implications for trifunctional antibody immunotherapy of cancer

Peter Ruf, Olivier Gires, Michael Jäger et al. · British Journal of Cancer · 2007 · 100 citations · Full text

Adoptive therapy of head and neck squamous cell carcinoma with antibody coated immune cells: a pilot clinical trial

Herbert Riechelmann, Markus Wiesneth, Peter Schauwecker et al. · Cancer Immunology Immunotherapy · 2007 · 30 citations · Full text

, , +13

Function, oligomerization, and conformation of tumor-associated p53 proteins with mutated C-terminus

Judith Atz, Peter Wagner, Klaus Roemer · Journal of Cellular Biochemistry · 2000 · 27 citations · Full text

Nintedanib Plus Docetaxel After Progression on Immune Checkpoint Inhibitor Therapy: Insights from VARGADO, A Prospective Study in Patients with Lung Adenocarcinoma

Christian Grohé, Wolfgang Gleiber, Siegfried Haas et al. · Future Oncology · 2019 · 25 citations · Full text

Rows per page

1–5 of 10